EW vs NVAX · P/E 47, rev $3.39B vs P/E 2.5, rev $196.2M
Edwards Lifesciences Corp (EW) versus Novavax Inc (NVAX) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Novavax Inc (NVAX) is a biotechnology company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
EW currently screens at market cap $49.91B and trailing P/E 46.9. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Not investment advice. Open the EW and NVAX stock pages for the full models.
Not investment advice.